Scrip : Jupiter Bioscience

CMP : 99.5

Target : 120 (Short Term) | 145 (Medium term)

Why ? : The book Value of this share is Rs 200.85/- i.e. if the co. gets closed a share holder receives Rs 200.85 on per share held. And the CMP is 99.5 so the book value is double of CMP and the share looks undervalued.

Buy or Cry the stock will fire!!!

Rakesh Jhunjhunwala has always been a role model for Value Investors in India. He is been termed as the Indian Warren Buffett. He is a person who became a billionaire just by investing in stocks.

Check out his latest portfolio : http://www.squamble.com/?p=2364

Stock : Alok Industries Ltd.

CMP :  24.6

Targets : 30 – 32

Time Frame : 1 – 1.5 months.

Stop Loss : 21

Buy this stock below 24 range. This stock is also one of the safest stock for long term.

It has good fundamentals too and also pays dividend.

HEG stock has moved up 53% from Nov 5 and has gained 12% since Dec 16 with the volumes rising 1.67 times.

Trading Delight

Volume 1.67 times higher than 5 day simple moving average
Trading above 5, 10 and 20 day moving average
Delivery fell to 10.93% from 3 month average of 50.17%

Delivery Pattern

22 dec                          10.93%
21 dec                          9.12%
18 dec                          6.5%
17 dec                          25.21%
3 mth avg                     50.10%

Volume

(fig in Lakh)
Volume            15 day avg vol
22 Dec              1.21                 0.72
21 Dec              3.58                 0.67
18 Dec              2.34                 0.45
17 Dec              2.00                 0.30

Demand Environment

Outlook for co seem to be improving with better visibility of volumes
Mgmt more optimistic for its FY 10 volume
Currently has 50-55% order book, which was certain to achieve few mth back

Capacity Utilisation

Currently operating at 60-65% capacity utilization
Expects to increase it to 70-75% in the latter part of the financial year

Realisation Picture

Gaining from higher realizations for graphite electrode
Reduction in raw material costs except for needle coke will increase realization
Entire cost hike of needle coke is getting passed
Maintain FY09 profitability or slightly increase
Expected to make additional profits from the sale of surplus power in the merchant market
Power sales is expected to generate additional profits of Rs33.4 cr in FY10
35% production cut enables the company to sell surplus power in the merchant market

Expansion Plan

Not done any employee addition in increasing its capacities from 30,000tpa to 60,000tpa
To increase its capacities to 80,000tpa by CY11-12
Process of increasing graphite electrode capacities to 66,000tpa by Dec’09  by at a capex of Rs42 cr

Script: Hotel Leela Ventures Ltd.

BSE: 500193

CMP: Rs. 44.40/-

52 Week H/L: 46.20 – 16.00

PE Ratio: 11.92

EPS: 3.84 Face Value: Rs2/-

Last dividend: 20% on 29/06/2009

Download the PDF file containing full stock analysis.

Hope you are subscribed to Free SMS Updates and Free E Mail updates so we can send you alert when we publish such analysis next time.